What is The Oncology Institute, Inc. (TOIIW)?

The Oncology Institute, Inc. (TOIIW) is a stock in the Healthcare sector, Medical - Care Facilities industry. View full analysis on Stocks360.

What is the current price of TOIIW?

The current price of TOIIW is $0.05. Prices are updated in real time on Stocks360.

What is TOIIW's price-to-earnings (PE) ratio?

TOIIW's trailing twelve-month PE ratio is -0.16, based on current price and earnings per share data available on Stocks360.

What is TOIIW's market capitalization?

TOIIW's market capitalization is $4,672,063.00, placing it in the small-cap tier.

The Oncology Institute, Inc. (TOIIW)

Stock analysis · NASDAQ · Healthcare · Medical - Care Facilities

$0.05

Market Cap

$4.67M

PE (TTM)

-0.16

EPS (TTM)

N/A

Dividend Yield

0.00%

Beta

0.42

Day Range

$0.05 – $0.05

52-wk Range

$0.05 – $0.18

Avg Volume

N/A

Volume

5.00

The Oncology Institute, Inc. (TOIIW) is a publicly traded company in the Healthcare sector. Latest price: $0.05. Market cap $4.67M. Trailing PE -0.16. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

You have viewed 4 SEO analysis pages

Unlock saved watchlists, personalized setups, and referral credits with a free Stocks360 account.

Continue with free signup

1-Year Price

2025-10-30 · $0.26 2026-08-03 · $0.05 (-81.69%)

Earnings

Most Recent

May 7, 2026

EPS $-0.02 vs est. $-0.09

Beat by $0.07

Proprietary Signals

Signal snapshot temporarily unavailable.

About The Oncology Institute, Inc.

The Oncology Institute, Inc. operates as a U.S.-based firm, specializing in providing extensive medical oncology services. Its comprehensive offerings encompass direct physician care, integrated on-site infusion and pharmacy services, clinical research initiatives, outpatient stem cell transplant and transfusion programs, and dedicated patient support. The company also oversees and manages specialized programs, including palliative care and stem cell transplants, specifically designed to meet the needs of cancer patients. Established in 2007, its headquarters are located in Cerritos, California.

Valuation

Trailing twelve months. Multiples relative to current market price.
P/E (TTM)	-0.16×
P/S (TTM)	0.01×
P/B	-1.96×
P/FCF (TTM)	-1.42×
EV / EBITDA	-3.11×
EV / Sales	0.12×
Earnings Yield	-74.31%
Free Cash Flow Yield	-70.33%

Fundamentals

Trailing twelve months. Source: financial statements via market data.
Enterprise Value	$68.05M
Revenue (TTM)	$587.24M
Net Income (TTM)	-$3.47M
Free Cash Flow (TTM)	$4.34M
Net Debt	$63.38M
Working Capital	$34.05M
Gross Margin	14.24%
Operating Margin	-4.44%
Net Margin	-6.18%
Return on Equity	209.81%
Return on Invested Capital	-28.82%